TY - JOUR AU - Mulders, T. A. AU - Björn, E. W. PY - 2019 DA - 2019// TI - Targeting the immune microenvironment in lymphomas of B- cell origin: from biology to clinical application JO - Cancers (Basel) VL - 11 UR - https://doi.org/10.3390/cancers11070915 DO - 10.3390/cancers11070915 ID - Mulders2019 ER - TY - JOUR AU - Scott, D. W. AU - Gascoyne, R. D. PY - 2014 DA - 2014// TI - The tumour microenvironment in B cell lymphomas JO - Nat VL - 14 ID - Scott2014 ER - TY - STD TI - Xu B, Wang T. Intimate cross-talk between cancer cells and the tumor microenvironment of B-cell lymphomas: the key role of exosomes. Tumor Biol. 2017;39:1–12. ID - ref3 ER - TY - JOUR AU - Sin Yee Guna, S. Y. AU - Ling Lee, S. W. PY - 2019 DA - 2019// TI - Targeting immune cells for cancer therapy JO - Redox Biol. VL - 25 UR - https://doi.org/10.1016/j.redox.2019.101174 DO - 10.1016/j.redox.2019.101174 ID - Sin Yee Guna2019 ER - TY - JOUR AU - Ribrag, V. AU - Koscielny, S. PY - 2016 DA - 2016// TI - Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial JO - Lancet. VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)01317-3 DO - 10.1016/S0140-6736(15)01317-3 ID - Ribrag2016 ER - TY - JOUR AU - Ngoma, T. AU - Adde, M. PY - 2012 DA - 2012// TI - Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease JO - Br J Haematol VL - 158 UR - https://doi.org/10.1111/j.1365-2141.2012.09236.x DO - 10.1111/j.1365-2141.2012.09236.x ID - Ngoma2012 ER - TY - STD TI - God JM, Haque A. Immune evasion by B-cell lymphoma. J Clin Cell Immunol. 2011;16:1–3. ID - ref7 ER - TY - JOUR AU - Gopal, S. AU - Gross, T. G. PY - 2018 DA - 2018// TI - How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa JO - Blood VL - 132 UR - https://doi.org/10.1182/blood-2018-04-844472 DO - 10.1182/blood-2018-04-844472 ID - Gopal2018 ER - TY - JOUR AU - Bouda, G. C. AU - Traorè, F. PY - 2019 DA - 2019// TI - Advanced Burkitt lymphoma in sub-Saharan Africa pediatric units: results of the third prospective multicenter study of the Groupe Franco-Africain d’Oncologie Pediatrique JO - J Glob Oncol VL - 5 UR - https://doi.org/10.1200/JGO.19.11000 DO - 10.1200/JGO.19.11000 ID - Bouda2019 ER - TY - JOUR AU - Silva, W. F. D. AU - Garibaldi, P. M. M. PY - 2019 DA - 2019// TI - Outcomes of HIV-associated Burkitt lymphoma in Brazil: high treatment toxicity and refractoriness rates - a multicenter cohort study JO - Leuk Res VL - 10 ID - Silva2019 ER - TY - JOUR AU - Ford, C. A. AU - Petrova, S. PY - 2015 DA - 2015// TI - Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma JO - Curr Biol VL - 25 UR - https://doi.org/10.1016/j.cub.2014.12.059 DO - 10.1016/j.cub.2014.12.059 ID - Ford2015 ER - TY - JOUR AU - Pham, L. V. AU - Pogue, E. PY - 2018 DA - 2018// TI - The role of macrophage/B-cell interactions in the pathophysiology of B-cell lymphomas JO - Front Oncol VL - 8 UR - https://doi.org/10.3389/fonc.2018.00147 DO - 10.3389/fonc.2018.00147 ID - Pham2018 ER - TY - JOUR AU - Kumar, D. AU - Xu, M. L. PY - 2018 DA - 2018// TI - Microenvironment cell contribution to lymphoma immunity JO - Front Oncol VL - 8 UR - https://doi.org/10.3389/fonc.2018.00288 DO - 10.3389/fonc.2018.00288 ID - Kumar2018 ER - TY - JOUR AU - Majzner, R. G. AU - Simon, J. S. PY - 2017 DA - 2017// TI - Assessment of programmed death-ligand 1 expression and tumor- associated immune cells in pediatric cancer tissues JO - Cancer VL - 123 UR - https://doi.org/10.1002/cncr.30724 DO - 10.1002/cncr.30724 ID - Majzner2017 ER - TY - JOUR AU - Chen, B. J. AU - Chapuy, B. PY - 2013 DA - 2013// TI - PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies JO - Human Cancer Biology VL - 19 ID - Chen2013 ER - TY - JOUR AU - Tan, G. W. AU - Visser, L. PY - 2018 DA - 2018// TI - The microenvironment in Epstein–Barr virus-associated malignancies JO - Pathogens VL - 7 UR - https://doi.org/10.3390/pathogens7020040 DO - 10.3390/pathogens7020040 ID - Tan2018 ER - TY - JOUR AU - Rowe, M. AU - Fitzsimmons, L. PY - 2014 DA - 2014// TI - Epstein-Barr virus and Burkitt lymphoma JO - Chin J Cancer VL - 33 ID - Rowe2014 ER - TY - JOUR AU - Dolcetti, R. PY - 2015 DA - 2015// TI - Cross-talk between Epstein-Barr virus and microenvironment in the pathogenesis of lymphomas JO - Semin Cancer Biol VL - 34 UR - https://doi.org/10.1016/j.semcancer.2015.04.006 DO - 10.1016/j.semcancer.2015.04.006 ID - Dolcetti2015 ER - TY - STD TI - Dojcinov, S.D.; Fend, F. EBV-positive Lymphoproliferations of B- T- and NK-cell derivation in non-Immunocompromised hosts. Pathogens. 2018;7:2–45. ID - ref19 ER - TY - JOUR AU - Linke-Serinsöz, E. AU - Fend, F. AU - Quintanilla-Martinez, L. PY - 2017 DA - 2017// TI - Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point JO - Semin Diagn Pathol VL - 34 UR - https://doi.org/10.1053/j.semdp.2017.04.003 DO - 10.1053/j.semdp.2017.04.003 ID - Linke-Serinsöz2017 ER - TY - STD TI - Granai M, Ambrosio MR. Role of Epstein Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature. Haematol. 2019;104:269–73. ID - ref21 ER - TY - JOUR AU - Rivera-Soto, R. AU - Damania, B. PY - 2019 DA - 2019// TI - Modulation of Angiogenic processes by the human Gammaherpesviruses, Epstein–Barr Virus and Kaposi’s Sarcoma-Associated Herpesvirus JO - Front Microbiol VL - 10 UR - https://doi.org/10.3389/fmicb.2019.01544 DO - 10.3389/fmicb.2019.01544 ID - Rivera-Soto2019 ER - TY - JOUR AU - Chen, B. AU - Khodadoust, M. S. PY - 2018 DA - 2018// TI - Profiling tumor infiltrating immune cells with CIBERSORT JO - Methods Mol Biol VL - 1711 UR - https://doi.org/10.1007/978-1-4939-7493-1_12 DO - 10.1007/978-1-4939-7493-1_12 ID - Chen2018 ER - TY - JOUR AU - Piccaluga, P. P. AU - Falco, G. PY - 2011 DA - 2011// TI - Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2010-08-301556 DO - 10.1182/blood-2010-08-301556 ID - Piccaluga2011 ER - TY - BOOK AU - Swerdlow, S. H. AU - Campo, E. PY - 2008 DA - 2008// TI - WHO classification of Tumours of Haematopoietic and lymphoid tissues PB - IARC CY - Lyon ID - Swerdlow2008 ER - TY - JOUR AU - Marafioti, T. AU - Paterson, J. C. PY - 2010 DA - 2010// TI - The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation JO - Haematol VL - 95 UR - https://doi.org/10.3324/haematol.2009.010991 DO - 10.3324/haematol.2009.010991 ID - Marafioti2010 ER - TY - STD TI - Abate F, Ambrosio MR. Distinct viral and mutational Spectrum of endemic Burkitt lymphoma. PLoS Pathog. 2015;11. ID - ref27 ER - TY - STD TI - Parra ER, Uraoka N. Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues. Sci Rep. 2017;7:1–11. ID - ref28 ER - TY - JOUR AU - Fowler, N. H. AU - Cheah, C. Y. PY - 2016 DA - 2016// TI - Role of the tumor microenvironment in mature B-cell lymphoid malignancies JO - Haematol VL - 101 UR - https://doi.org/10.3324/haematol.2015.139493 DO - 10.3324/haematol.2015.139493 ID - Fowler2016 ER - TY - JOUR AU - Shain, K. H. AU - Dalton, W. S. PY - 2015 DA - 2015// TI - The tumor microenvironment shapes hallmarks of mature B-cell malignancies JO - Oncogene VL - 34 UR - https://doi.org/10.1038/onc.2014.403 DO - 10.1038/onc.2014.403 ID - Shain2015 ER - TY - JOUR AU - Wang, M. AU - Zhao, J. PY - 2017 DA - 2017// TI - Role of tumor microenvironment in tumorigenesis JO - J Cancer VL - 8 UR - https://doi.org/10.7150/jca.17648 DO - 10.7150/jca.17648 ID - Wang2017 ER - TY - JOUR AU - Xue, J. AU - Schmidt, S. V. PY - 2014 DA - 2014// TI - Transcriptome-based network analysis reveals a Spectrum model of human macrophage activation JO - Immunity VL - 40 UR - https://doi.org/10.1016/j.immuni.2014.01.006 DO - 10.1016/j.immuni.2014.01.006 ID - Xue2014 ER - TY - JOUR AU - Steidl, C. AU - Lee, T. PY - 2010 DA - 2010// TI - Tumor-associated macrophages and survival in classic Hodgkin's lymphoma JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0905680 DO - 10.1056/NEJMoa0905680 ID - Steidl2010 ER - TY - JOUR AU - Li, Y. L. AU - Shi, Z. H. PY - 2019 DA - 2019// TI - Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count JO - BMC Cancer VL - 19 UR - https://doi.org/10.1186/s12885-019-6208-x DO - 10.1186/s12885-019-6208-x ID - Li2019 ER - TY - JOUR AU - Larionova, I. AU - Cherdyntseva, N. PY - 2019 DA - 2019// TI - Interaction of tumor-associated macrophages and cancer chemotherapy JO - Oncoimmunology VL - 8 UR - https://doi.org/10.1080/2162402X.2019.1596004 DO - 10.1080/2162402X.2019.1596004 ID - Larionova2019 ER - TY - JOUR AU - Komohara, Y. AU - Niino, D. PY - 2013 DA - 2013// TI - Clinical significance of CD163+ tumor-associated macrophages in patients with adult T-cell leukemia / lymphoma JO - Cancer Sci VL - 104 UR - https://doi.org/10.1111/cas.12167 DO - 10.1111/cas.12167 ID - Komohara2013 ER - TY - JOUR AU - Bingle, L. AU - Brown, N. J. PY - 2002 DA - 2002// TI - The role of tumour associated macrophages in tumour progression: implications for new anticancer therapies JO - J Pathol VL - 196 UR - https://doi.org/10.1002/path.1027 DO - 10.1002/path.1027 ID - Bingle2002 ER - TY - JOUR AU - Nam, S. J. AU - Go, H. PY - 2014 DA - 2014// TI - An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone JO - Leuk Lymphoma VL - 55 UR - https://doi.org/10.3109/10428194.2013.879713 DO - 10.3109/10428194.2013.879713 ID - Nam2014 ER - TY - STD TI - Jiang Y, Li Y. T-cell exhaustion in the tumour microenviroment. Cell Death Dis. 2015;6:1–9. ID - ref39 ER - TY - JOUR AU - Butte, M. J. AU - Keir, M. E. PY - 2007 DA - 2007// TI - Programmed death-1 ligand 1 interacts specifically with the B7–1 costimulatory molecule to inhibit T cell responses JO - Immunity VL - 27 UR - https://doi.org/10.1016/j.immuni.2007.05.016 DO - 10.1016/j.immuni.2007.05.016 ID - Butte2007 ER - TY - STD TI - Rollins MR, Gibbons Johnson RM. CD80 expressed by CD8(+) T cells contributes to PD-L1-induced apoptosis of activated CD8(+) T cells. J Immunol Res. 2017;2017:1–6. ID - ref41 ER - TY - JOUR AU - Cirone, M. AU - Lucania, G. PY - 2007 DA - 2007// TI - Human Herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their Immunostimulatory activity JO - Immunol Lett VL - 113 UR - https://doi.org/10.1016/j.imlet.2007.07.013 DO - 10.1016/j.imlet.2007.07.013 ID - Cirone2007 ER - TY - JOUR AU - Larbcharoensub, N. AU - Mahaprom, K. PY - 2018 DA - 2018// TI - Characterization of PD-L1 and PD-1 expression and CD8+ tumor-infiltrating lymphocyte in Epstein-Barr virus-associated nasopharyngeal carcinoma JO - Am J Clin Oncol VL - 41 UR - https://doi.org/10.1097/COC.0000000000000449 DO - 10.1097/COC.0000000000000449 ID - Larbcharoensub2018 ER - TY - JOUR AU - Shayan, G. AU - Ferris, R. L. PY - 2015 DA - 2015// TI - PD-1 blockade upregulate TIM-3 expression as a compensatory regulation of immune check point receptors in HNSCC TIL JO - J Immunother Cancer VL - 3 UR - https://doi.org/10.1186/2051-1426-3-S2-P196 DO - 10.1186/2051-1426-3-S2-P196 ID - Shayan2015 ER - TY - STD TI - Bi X, Wang H. PD-L1 is upregulated by EBV- driven LMP1 through NF-kB pathway and correlates with poor prognosis in natural killer /T-cell. J Hematol Oncol. 2016;9:109–21. ID - ref45 ER - TY - STD TI - Hudnall SD, Küppers R. Precision molecular pathology of Hodgkin lymphoma. 1st ed. PLOS Pathogens; 2018. ID - ref46 ER - TY - STD TI - Wasil LR, Tomaszewski MJ. The effect of Epstein-Barr virus latent membrane protein 2 expression on the kinetics of early B cell infection. PLoS One. 2013;8:1–14. ID - ref47 ER - TY - JOUR AU - Deb Pal, A. AU - Banerjee, S. PY - 2015 DA - 2015// TI - Epstein–Barr virus latent membrane protein 2A mediated activation of sonic hedgehog pathway induces HLA class Ia downregulation in gastric cancer cells JO - Virology VL - 484 UR - https://doi.org/10.1016/j.virol.2015.05.007 DO - 10.1016/j.virol.2015.05.007 ID - Deb Pal2015 ER - TY - STD TI - Rancan C, Schirrmann L. Latent membrane protein LMP2A impairs recognition of EBV- infected cells by CD8+ T cells. PLoS Pathog. 2015;11:1–23. ID - ref49 ER - TY - JOUR AU - Yang, L. AU - Huang, F. PY - 2017 DA - 2017// TI - Posttranscriptional control of PD-L1 expression by 17β-estradiol via PI3K/Akt signaling pathway in ERα-positive Cancer cell LinesInternational journal of gynecologic JO - Cancer VL - 27 ID - Yang2017 ER - TY - STD TI - Kristin J. Lastwika, Willie Wilson III, Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer Cancer Res January 15 2016 (76) (2) 227–238;. ID - ref51 ER - TY - JOUR AU - Gao, Y. AU - Yang, J. PY - 2018 DA - 2018// TI - IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling JO - Int J Cancer VL - 143 UR - https://doi.org/10.1002/ijc.31357 DO - 10.1002/ijc.31357 ID - Gao2018 ER -